Now showing items 1-1 of 1
Fabrication of a novel radiopharmaceutical: lutetium-177 loaded MCM-41mesoporous silica
(University of Missouri--Columbia, 2014)
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Targeted therapy of cancer, by binding the radionuclide with a carrier agent, provides more accurate delivery to focal tumor cell with low uptake in ...